PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Supplementation of mulberry leaf/extract resulted in a significant reduction of glycemic traits [PMID:36644880]. In a trial of 60 patients, 300 mg of extract twice daily significantly decreased insulin and malondialdehyde (MDA) and increased HDL-cholesterol [PMID:35623877].
Different doses of Reducose mulberry leaf extract were investigated for their ability to lower glycemic and insulinemic responses to a meal in healthy individuals [PMID:38892603].
A blend containing 750 mg of mulberry leaf extract and tryptophan was evaluated for benefits on sleep onset latency and efficiency in adults with sleep complaints [PMID:40072601].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 40527063 (2025) — Mulberry leaf improves type 2 diabetes in mice via gut microbiota-SCFAs-GPRs axis and AMPK signaling pathway. · Phytomedicine : international journal of phytotherapy and phytopharmacology
- 2.PMID: 38892603 (2024) — Understanding the Impact of Different Doses of Reducose® Mulberry Leaf Extract on Blood Glucose and Insulin Responses after Eating a Complex Meal: Results from a Double-Blind, Randomised, Crossover Trial. · Nutrients
- 3.PMID: 36770881 (2023) — Biosynthesized Silver Nanoparticles Using Morus alba (White Mulberry) Leaf Extract as Potential Antibacterial and Anticancer Agents. · Molecules (Basel, Switzerland)
- 4.PMID: 40678263 (2025) — Oral oncolytic magnetotactic bacteria elicit anti-colorectal tumor immunity and reprogram microbiota metabolism. · Bioactive materials
- 5.PMID: 41004579